Shuttle Pharmaceuticals Holdings, Inc.
SHPHNasdaq
$3.16
↓ -11.0%Jul 17 close · end-of-day
Price
1Y↓ -91.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$15.9M
Enterprise Value
$14.8M
P/E
316.0
P/S
—
P/B
4.8
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$10.8M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-323.4%
ROIC
-391.5%
Debt / Equity
—
Net Cash
$1.1M
Return 1Y
-92.0%
Company profile
Founded in 2012 by faculty members of the Georgetown University Medical Center, Shuttle Pharmaceuticals is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT). The Company was formed as a limited liability company in the state of Maryland in December 2012 and was converted to a C corporation, Shuttle Pharmaceuticals, Inc. (“Shuttle”), in August of 2016. In June 2018, Shuttle completed a share exchange with Shuttle Pharma Acquisition Corp. Inc. (“Acquisition Corp.”), pursuant to which Shuttle Pharmaceuticals, Inc. became a subsidiary of Acquisition Corp. and we subsequently changed the name of Acquisition Corp. to Shuttle Pharmaceuticals Holdings, Inc. Our executive offices are located at 1 Research Court, Suite 450, Rockville, Maryland.
- CEO
- Anatoly Dritschilo
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 5
- Headquarters
- Maryland
- Website
- shuttlepharma.com
Earnings
SHPH Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$0.43↓ -94.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$1.7M | -$2.3M | -$5.9M | -$7.7M | -$11.9M |
| Net income | -$1.2M | -$5.0M | -$6.6M | -$9.1M | -$11.7M |
| Diluted EPS | — | -$5.04 | -$3.53 | -$82.60 | -$7.16 |
| Operating cash flow | -$300,336.00 | -$2.7M | -$5.6M | -$7.3M | -$9.5M |
| Free cash flow | — | — | -$5.6M | — | — |
| Gross margin | — | — | — | — | — |
| Operating margin | — | — | — | — | — |
| Net margin | — | — | — | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$1.5M | -$3.1M | -$1.8M | -$3.0M | -$3.9M | -$2.3M | -$2.8M | -$2.2M |
| Net income | -$2.0M | -$3.8M | -$1.6M | -$3.1M | -$3.7M | -$2.3M | -$2.6M | -$2.2M |
| Diluted EPS | -$24.12 | -$39.83 | -$17.82 | -$7.60 | -$3.29 | -$1.05 | $4.78 | -$0.43 |
| Operating cash flow | -$1.4M | -$2.0M | -$2.7M | -$2.5M | -$3.4M | -$2.6M | -$973,012.00 | -$2.4M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Jun 26, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-14 | HRT FINANCIAL LLC | Sale | 82,116 | $4.48 | $367,879.68 | filing |
| 2026-07-13 | HRT FINANCIAL LLC | Sale | 1,033 | $4.67 | $4,824.11 | filing |
| 2026-07-10 | HRT FINANCIAL LLC | Buy | 731 | $3.11 | $2,273.41 | filing |
| 2026-07-09 | HRT FINANCIAL LLC | Buy | 8,266 | $3.38 | $27,939.08 | filing |
| 2026-07-08 | HRT FINANCIAL LLC | Sale | 18,531 | $3.52 | $65,229.12 | filing |
| 2026-07-07 | HRT FINANCIAL LLC | Sale | 10,580 | $3.33 | $35,231.40 | filing |
| 2026-07-06 | HRT FINANCIAL LLC | Sale | 9,022 | $3.51 | $31,667.22 | filing |
| 2026-07-02 | HRT FINANCIAL LLC | Buy | 7,851 | $3.54 | $27,792.54 | filing |
| 2026-07-01 | HRT FINANCIAL LLC | Buy | 3,959 | $3.30 | $13,064.70 | filing |
| 2026-06-30 | HRT FINANCIAL LLC | Buy | 6,755 | $3.23 | $21,818.65 | filing |
| 2026-06-29 | HRT FINANCIAL LLC | Buy | 25,836 | $3.44 | $88,875.84 | filing |
Latest 11 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.